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 Introduction: The U.S. FDA can regulate tobacco products under the Family Smoking 
Prevention and Tobacco Control Act, creating the potential for new cigarette standards aiming to 
reduce harm. Nicotine content could be a target of regulation, since nicotine drives cigarette 
addiction (Stolerman & Jarvis, 2005), though the FDA cannot mandate zero nicotine (Congress, 
2009). The FDA may consider enacting a reduced nicotine product standard for all cigarettes, as 
the use of very low nicotine content (VLNC) cigarettes (i.e. 0.05 mg nicotine yield) has been 
shown to decrease smoking rate and dependence over time (Hatsukami, et al., 2010). However, 
most studies of VLNC cigarettes to date have blinded subjects to the nicotine content, so little is 
known about how smokers perceive cigarettes with known very low nicotine levels and how this 
knowledge impacts cigarette use. Methods: The present study was a within-subjects experiment 
with 68 adult daily smokers who tried two identical Quest 3 (0.05 mg nicotine yield) cigarettes in 
a single session (counterbalanced order). Before smoking they were told that one cigarette 
contained “average” nicotine, and the other contained “very low” nicotine. Smokers rated each 
cigarette on several measures after sampling them. Results: Smokers rated the “very low” 
nicotine cigarette as less risky overall than the “average” nicotine cigarette (p=0.001); this effect 
held true for specific diseases including lung cancer, heart disease, emphysema, stroke, chronic 
bronchitis, and other cancers (p’s <0.001). Additionally, smokers rated the “very low” nicotine 
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cigarette as having less desirable subjective effects than the “average” nicotine cigarette, 
including reduced satisfaction, psychological reward, and enjoyment of respiratory sensations 
(p’s<0.05). Moreover, smokers predicted having greater interest in quitting smoking in 1 month, 
6 months, and 1 year (p’s <0.02) when considering exclusive availability of the “very low” 
nicotine cigarette. Similarly, more smokers predicted being abstinent in 5 years when 
considering exclusive availability of the “very low” nicotine cigarette (p=0.04). Conclusions: 
Explicit knowledge of very low nicotine content changes smokers’ perceptions of VLNC 
cigarettes, resulting in reduced predicted harm, subjective effects and predicted use. 
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1.0  INTRODUCTION 
Though the prevalence of cigarette smoking has declined over the past several decades, it 
remains the leading cause of preventable death in the U.S. (CDC, 2008). Tobacco control efforts 
are increasing with the aim of decreasing morbidity and mortality. One potential policy with 
some empirical support is the reduction of nicotine in cigarettes to a level below the “addictive 
threshold.” Theoretically, exclusive availability of cigarettes with nicotine levels below this 
threshold would decrease both smoking uptake in youth and smoking in established smokers. It 
is primarily through these two pathways that very low nicotine content (VLNC) cigarettes could 
decrease the morbidity and mortality associated with smoking, by reducing exposure to 
particulates, oxidant chemicals, polycyclic aromatic hydrocarbons (PAHs), carbon monoxide 
(CO), and nitrosamines. Several studies have explored the effect of extended use of VLNC 
cigarettes and these studies generally support the notion that a nicotine reduction policy might 
facilitate decreased smoking (Donny, Houtsmuller, & Stitzer, 2007; Benowitz, et al., 2007; 
Hatsukami, et al., 2010; Benowitz, et al., 2012).  
Before implementing a nicotine reduction policy, the FDA should consider possible 
unintended consequences such as reduced perceived harm. Though the use of descriptors such as 
“low”, “light”, and “mild” on cigarette packages are currently banned, smokers receive 
information about cigarettes in other ways (i.e. package coloring, media). It is important to 
explore whether knowledge that VLNC cigarettes contain low nicotine distorts smokers’ ideas 
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about their risk of developing smoking diseases, as risk perceptions are known to influence 
behavior (van der Pligt, 1998). Limited existing survey research has shown that many smokers 
hold erroneous beliefs about nicotine’s impact on smoking diseases (i.e. that nicotine causes lung 
cancer) (Cummings, Hyland, Bansal, & Giovino, 2004; Shadel et al, 2006; Bansal-Travers, et al., 
2010). Though VLNC cigarettes are expected to be less reinforcing, smokers may believe that 
they can continue to smoke them with fewer negative health consequences, thereby lowering 
their motivation to quit. Most experimental research conducted with VLNC cigarettes thus far 
has used blinding procedures such that smokers are not aware of the nicotine content, so the 
effect of very low nicotine content expectancy on risk perceptions in smokers actually trying 
these products is unclear. Previous work has identified that low nicotine/tar content expectancies 
of “light” cigarettes (though false) led to lower perceived harm and delayed cessation (Etter, 
Kozlowski, & Perneger, 2003; Shiffman, Pillitteri, Burton, Rohay, & Gitchell, 2001; Kozlowski, 
et al., 1998). Since “light” cigarettes claimed both low tar and low nicotine, it is unclear which 
factor was responsible for these misconceptions. Thus it is important that the effect of nicotine 
content expectancy on smoking risk perception be explored specifically in an experimental 
setting.  
Nicotine content expectancies also influence the subjective experience of smoking and 
the effects felt from using the cigarette. Studies have found significant influences of nicotine 
content expectancy on craving reduction, mood, wakefulness, calmness, concentration, 
satisfaction from smoking, and hunger reduction (Juliano & Brandon, 2002; Juliano, Fucito, & 
Harrell, 2011; Kelemen & Kaighobadi, 2007; Perkins, Jacobs, Ciccocioppo, et al., 2004). In 
addition, studies have explored the effect of nicotine content expectancies for other nicotine 
delivery products such as sprays and inhalers, and have found significant influences on 
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satisfaction and craving relief from these products (Perkins, Jacobs, Clark, et al., 2004, Perkins et 
al., 2009; Darredeau & Barrett, 2010). These studies suggest that the amount of nicotine one 
believes is in a nicotine product can supersede their experience of receiving a different nicotine 
amount and influence their smoking experience. The impact of nicotine content expectancies on 
subjective effects of smoking is important because it may influence the way cigarettes are used 
(i.e. feeling the need to smoke more).    
In addition to psychological constructs such as risk perception and subjective smoking 
effects, nicotine content expectancy might influence actual smoking-related behavior. One study 
exploring this effect by measuring puff count demonstrated an interaction between true nicotine 
content and nicotine content expectancy; for participants given truly average nicotine-containing 
cigarettes, the total number of puffs taken was greater when the cigarettes were described as 
nicotine-containing (compared to a nicotine free or placebo expectancy), but the opposite effect 
was found in smokers receiving a truly denicotinized cigarette (fewer puffs of the cigarette were 
taken when described as nicotine-containing) (Juliano, et al., 2011). A couple of studies have 
explored the effect of nicotine content expectancy on smoking behavior using a progressive ratio 
task. The first study found that only individuals who were given a truly denicotinized cigarette 
made greater total responses for smoke puffs (and thus achieved more self-administered cigarette 
puffs) when they were told the cigarette contained regular nicotine compared to a placebo 
expectancy (Perkins, Jacobs, Ciccocioppo, et al., 2004). This same nicotine content expectancy 
effect was found in another study using a progressive ratio task, but the effect held true 
regardless of the true nicotine content of the cigarette (Darredeau, Stewart, & Barrett, 2013). 
Though these studies demonstrate that there are effects of nicotine content expectancy on 
smoking behavior generally, they only describe effects of a placebo expectancy (zero nicotine), 
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and it is important that we understand how the effect of a very low nicotine content expectancy 
on smoking behavior may differ because the FDA cannot mandate a zero nicotine product 
standard. This question has never been specifically explored experimentally.  
However, there have been two studies exploring the effects of prolonged use of VLNC 
cigarettes that disclosed the reduced nicotine content to subjects switched to these products 
(Benowitz, et al., 2007; Benowitz, et al., 2012). These two studies did not demonstrate the same 
decreased smoking rate that other blinded studies (Donny, Houtsmuller, & Stitzer, 2007; 
Hatuskami, et al., 2010) demonstrated, which may suggest that a lower nicotine content 
expectancy blunts the effect of VLNC cigarettes on smoking rate. However, it is important to 
note that other study design differences could be responsible for the difference in smoking 
behavior results; namely that these subjects’ nicotine levels were dropped progressively over 
time as opposed to abruptly and they were not treatment seeking. Overall, there is mixed 
evidence and little understanding about the effect of nicotine content expectancy on smoking 
behavior, and there has never been an experimental study that has specifically explored a very 
low nicotine content expectancy. 
The present experimental study investigated the effect of a very low nicotine content 
expectancy on cigarette health risk perceptions, subjective cigarette effects, and both short-term 
and predicted long-term future smoking behavior. Nicotine content expectancies were 
manipulated using an instructional set, and included “very low” and “average” nicotine content. 
In both conditions, the same type of VLNC cigarette (Quest brand, 0.05 mg nicotine yield) was 
smoked through a puff topography device. In a within-subjects design, subjects underwent both 
conditions during a single session in counterbalanced order. Subjects completed cigarette ratings 
after smoking each cigarette; this design aimed to determine whether the nicotine content 
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expectancy and its effects on dependent measures persisted after smokers experienced the true 
nicotine level. It was predicted that the “very low” nicotine cigarette would be perceived as less 
risky for contributing to various smoking-related diseases, rated as less subjectively desirable, 
and smoked more intensely through the puff topography devices. It was also hypothesized that 
smokers would predict higher smoking rate and/or lower interest in quitting in the future when 
considering the exclusive availability of the “very low” nicotine cigarette due to reduced health 
risk perceptions.  
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2.0  METHOD 
2.1 PARTICIPANTS 
Current daily smokers aged 18 and older who had smoked at least 10 cigarettes per day for at 
least one year were recruited from the Pittsburgh community via Internet and flyer 
advertisements. Exclusion criteria included significant medical changes in the previous week that 
contraindicated smoking (i.e. myocardial infarction), currently seeking treatment to quit 
smoking, alcohol intoxication at the time of the visit, and pregnancy/breastfeeding. Participants 
had to demonstrate a carbon monoxide level of at least 8 ppm (or NicAlert cotinine strip level of 
at least 3) to be eligible for the study. 
2.2 PROCEDURES 
Prior to study participation, volunteers provided verbal consent to be screened over the telephone 
by research assistants. All volunteers were asked about their smoking history and recent health 
changes. Female volunteers were asked if they are pregnant or breastfeeding. Volunteers 
determined to be eligible were scheduled for the study session, which lasted approximately three 
hours. At the start of the study session, volunteers first read and signed the informed consent 
document before completing the in-person screening procedures. Smoking status was determined 
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via expired breath carbon monoxide (CO) level (at least 8 ppm) using a Microlyzer, or urine 
cotinine testing (at least level 3 on NicAlert strip) if CO was below 8 ppm. Volunteers needed to 
demonstrate a breath alcohol level (BAL) less than or equal to 0.01% to continue with the visit. 
Volunteers whose first BAL fell between 0.011-0.03% were allowed to wait in the laboratory 
(for up to 30 minutes) until it dropped to 0.01%. Any volunteers who did not meet one or more 
of these requirements were dismissed from the study without payment. Volunteers that did not 
meet the BAL requirement only were allowed to return once another day to screen again. 
Volunteers that passed the screening procedures were then assigned a randomization code that 
determined the order of study conditions they would complete. Two identical randomization 
schedules were used separately for males and females. 
Eligible participants first completed the baseline questionnaire battery on MediaLab 
software. Carbon monoxide was measured again four minutes before participants smoked their 
preferred brand cigarette. Participants then smoked four puffs of their usual brand cigarette 
through a handheld puff topography device in a well-ventilated smoking room. This primarily 
served to standardize the amount of time since each participant last smoked and allowed them to 
acclimate to the device. Participants then answered the cigarette rating measures in reference to 
their usual cigarette after they were finished smoking. Four minutes after finishing the cigarette, 
CO was measured again. The difference between their initial CO level and the post-smoking CO 
level (CO boost) was used as an index of smoke exposure.  
Next, participants tried the two study cigarettes at 45-minute intervals to avoid satiation. 
The first study cigarette was smoked 45 minutes after the usual brand cigarette. The cigarettes 
used in this study were Quest 3 brand cigarettes that were genetically modified to reduce the 
nicotine content, and the nicotine yield is 0.05 mg determined by the ISO method (tar yield is 
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approximately 10 mg). The Quest logo was crossed out with a black marker so that participants 
could not see the cigarette type. Carbon monoxide was measured four minutes before the 
participant smoked the study cigarette. The research assistant used the randomization code to 
determine the order of conditions while blind to which conditions were first and second.  
PowerPoint slideshows were used to instruct the participant during each condition. The 
slideshows for each condition differed in the screen that described the study cigarette to be 
smoked that time. The cigarette description screen appeared for 30 seconds and a recorded 
voiceover read the text aloud to ensure attention to the information. The text was as follows: 
“The next cigarette that you will be smoking contains a very low/average nicotine level, 
compared to most cigarettes available in the U.S. First, you will smoke as much or as little of this 
cigarette as you would like to smoke. Then, you will be asked to answer some questions about 
your opinions of the product.” 
The next screen of the slideshow instructed the participant to choose the corresponding 
study cigarette from a large manila envelope placed on the desk next to them. Inside the manila 
envelope, the participant found two smaller white envelopes labeled “very low nicotine 
cigarette” and “average nicotine cigarette.” The slideshow instructed the participant to place the 
small white envelope back into the large manila envelope to keep the research assistant blind. 
The participant was also instructed not to discuss with the research assistant which cigarette they 
smoked during each condition. The next slideshow screen instructed the participant to place the 
cigarette into the puff topography device, light it, and smoke as much as desired. The participant 
then completed the cigarette rating measures in reference to the study cigarette just smoked. 
After four minutes passed since smoking, CO was measured again to assess CO boost. This 
process was repeated for both study cigarettes.  
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 Participants were paid $50 plus transportation costs for completing the study. Participants 
received a debriefing letter in the mail once all recruitment was completed. Debriefing did not 
occur immediately following the visit to prevent future participants from being informed of the 
deception involved in this study.  
2.3 ASSESSMENTS 
2.3.1 Baseline Assessment 
Sample Characteristics. Demographic variables including age, gender, race, education, 
employment, and annual income were measured to characterize the diversity of the sample. 
Variables such as cigarettes per day, years of daily smoking, and menthol status were measured 
to characterize the type of smokers in the sample.  
Nicotine Dependence. The Fagerstrom Test for Nicotine Dependence (FTND; 
Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991) and Wisconsin Index of Smoking 
Dependence Motives - Brief Version (WISDM Brief; Smith et al., 2010) were used to measure 
the nicotine dependence of the sample. The FTND is a six-item, psychometrically validated 
measure that assesses both heaviness of smoking and behaviors that reflect nicotine dependence. 
The WISDM Brief is a psychometrically validated and multidimensional measure of tobacco 
dependence with 37 items (answered on a 1-7 Likert scale) that load onto 11 subscales, each 
measuring a distinct, theoretically-derived smoking motive. The subscales include affective 
enhancement, affiliative attachment, and automaticity, loss of control, cognitive enhancement, 
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craving, cue exposure /associative processes, social/environmental goads, taste /sensory 
properties, tolerance, and weight control. 
Interest in Quitting. Participants completed the Stages of Change Questionnaire 
(Prochaska & Goldstein, 1991) and Contemplation Ladder (Biener & Abrams, 1991). The Stages 
of Change Questionnaire assesses whether smokers are considering quitting smoking within the 
next 30 days or six months. On the Contemplation Ladder, smokers indicated which rung of a 
pictured ladder represented their current thinking about quitting. The ladder consists of rungs 
from level 0 to 10, with 0 representing “I am not ready to quit” and 10 representing “I am ready 
to quit now.” 
Impression Management. The Balanced Inventory of Desirable Responding (BIDR; 
Paulhus, 1991) is a 40-item scale designed to measure socially desirable responding to enhance 
self-presentation. Responses are given on a 7-point Likert scale from “not true” to “very true”. A 
sample question is I sometimes tell lies if I have to. This measure was given to determine whether 
effects of nicotine content expectancy on dependent measures were specific to individuals with 
high impression management. 
2.3.2 Cigarette Health Risk Perceptions 
The Perceived Health Risk Questionnaire (PHRQ; Hatsukami, et al., 2010) assessed smokers’ 
perceived risk for developing smoking-related health problems associated with each cigarette. 
Smokers were asked to assume the same smoking rate; thus, it was a measure of the perceived 
risk of the product itself. The measure includes eight items for which the participant responds on 
a 1-100 visual analog scale (very low risk to very high risk). The items include lung cancer, 
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emphysema, chronic bronchitis, other cancers, heart disease and stroke, overall health risk and 
risk of addiction.  
2.3.3 Cigarette Subjective Effects 
A modified version of the Cigarette Evaluation Scale (MCES; Westman, Levin, & Rose, 1992) 
was used to measure subjective cigarette effects. The MCES includes 15 items for which the 
participant responds on a 7-point Likert scale to report how much they agree with each statement 
(not at all to extremely). Cigarette effects measured include satisfaction, taste, enjoyment of 
sensations in throat/chest, harshness, strength, flavor, calming, awakening, less irritable, help 
concentrating, hunger reduction, dizzying, nauseating, craving reduction, and enjoyment. Five 
reliable factors can be derived from the MCES items including satisfaction (items include 
satisfaction, taste, and enjoyment), psychological reward (items include calming, awakening, less 
irritable, help concentrating, and hunger reduction), aversion (items include dizzying and 
nauseating), craving reduction, and enjoyment of respiratory tract sensations (enjoyment of 
sensations in throat/chest) (Cappelleri et al., 2007). An additional item was included in the 
MCES for the two study cigarettes to assess perceived level of nicotine. Smokers were asked, 
“How does the nicotine content of the study cigarette differ from your usual brand? Please 
answer on the following scale from 1-100, and imagine that your usual brand is 50.” The visual 
analog scale was anchored on the ends by “much less nicotine” and “much more nicotine.”  
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2.3.4 Puff Topography 
CReSS Version 3 handheld puff topography devices measured puff number, puff volume, puff 
duration, inter-puff-interval, peak flow, average flow, and time to peak flow. Devices were 
calibrated prior to each use. 
2.3.5 Predicted Future Smoking Behavior 
A novel survey named the Future Smoking Survey was created to assess how hypothetical 
exclusive availability of each type of cigarette would influence predicted smoking rate and 
interest in quitting smoking in the future. This assessment was designed to capture what 
participants think they would do in a regulated marketplace, similar to what would occur if the 
FDA were to enact a low nicotine product standard. Participants were asked to rate on a 1-100 
visual analog scale how interested they would be in quitting (not at all interested to definitely 
interested) at four future time points (in 1 month, 6 months, 1 year, and 5 years). Participants 
were also asked to predict how many cigarettes per day they would be smoking at each of those 
time points.  
In addition, participants completed the Cigarette Purchase Task (MacKillop et al., 2008), 
a self-report measure that assesses cigarette consumption at a range of increasing prices. The task 
is designed to assess the reinforcing value or abuse liability of a drug by assessing how elastic 
drug taking behavior is to price changes. For example, if consumption levels changed very little 
as price increased, this would indicate a highly reinforcing drug. The data collected with a 
Cigarette Purchase Task generates a demand curve, which depicts the relationship between 
demand for cigarettes and increases in price. Multiple indices of relative reinforcing efficacy are 
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captured, including: 1) breakpoint (the lowest price associated with zero consumption); 2) 
intensity (observed value of consumption at zero cost), 3) alpha (elasticity, or how sensitive 
consumption is to increases in cost), 4) Omax (the maximum expenditure for cigarettes), 5) 
Pmax (the price increment associated with maximum expenditure), and 6) Q0 (consumption at 
zero cost derived from demand equation). The instructions to this task read, “The following 
questions ask how many cigarettes you would consume within a 24-hour period if they cost 
various amounts of money. Assume the available cigarettes are your usual brand/the most recent 
study cigarette. Assume that you have the same income/savings that you have now and NO 
ACCESS to any cigarettes or nicotine products other than those offered at these prices. You 
cannot save or stockpile cigarettes for a later date.  Be sure to consider each price increment 
carefully.” The progression of prices was: free, 2 cents, 5 cents, 10 cents, 20 cents, 30 cents, 40 
cents, 50 cents, 60 cents, 70 cents, 80 cents, 90 cents, 1 dollar, 2 dollars, 3 dollars, 4 dollars, 5 
dollars.  
2.4 STATISTICAL METHODS 
The estimated necessary sample size was 55 participants, which was determined by a power 
analysis from preliminary data (9 participants), with d=0.45, a=0.05 (two-tailed test) and 90% 
power. Thus, the final sample size of 68 participants was expected to be sufficient to detect 
significant effects of nicotine content expectancy. Statistical analyses were conducted using 
SPSS 21 (SPSS, Chicago, IL). Descriptive statistics were used to characterize the sample’s 
demographic and smoking history variables, as well as ratings of the usual brand cigarette. No 
comparisons were made between the usual brand cigarette responses and study cigarette 
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responses because the usual brand cigarette was always smoked first, but descriptive data on 
responses to the usual brand cigarette are provided as a reference point. Paired-samples t-tests 
were used to compare normally distributed dependent variables across the two experimental 
conditions. Repeated measures ANOVA was used to test interactions between nicotine content 
expectancy and between-subjects variables including order of study conditions, gender, menthol 
status, and impression management score when appropriate. Non-normally distributed dependent 
variables were analyzed using the Wilcoxon matched pairs test. The McNemar’s test was used to 
assess differences in proportions.  
For the cigarette purchase task data, exponential demand equations were fit using Prism 5 
curve-fitting software (GraphPad, La Jolla, CA, USA) to determine the alpha and Q0 values. 
Since the GraphPad software uses logarithmic transformations in the analysis, the breakpoint 
response (first 0 response) was changed to 1 and all prior responses were increased by 1 to keep 
the relative difference between these responses and the breakpoint equal. Responses subsequent 
to the breakpoint were removed before analyzing the data. The k value used for the analyses was 
2 since responses ranged from 0 to 60 cigarettes per day (log10 60=1.78, which was rounded to 
the nearest whole number). In cases in which no breakpoint was reached, the breakpoint was 
defined as the highest price of $5 per cigarette. 
In addition, some participants misunderstood the wording of the questions on the Future 
Smoking Survey assessing predicted cigarettes per day at four future time points. There were 
responses in the thousands, indicating that participants mistakenly thought the question was 
asking about total cigarettes smoked over the time period assessed. To rectify this issue, any 
response over 100 cigarettes per day was excluded from analyses as this was chosen as the 
highest reasonable value for someone who understood the question. Furthermore, many 
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participants predicted smoking zero cigarettes per day in the future (at all four time points) if 
only these study cigarettes were available. Thus, two processes were explored with regard to the 
predicted cigarettes per day data. First, the percentage of zero cigarettes per day responses was 
compared across study cigarette types at each future time point using a McNemar’s Test. This 
captured the percentage of participants that predicted being abstinent. Secondly, the zero 
responses were removed and the remaining responses (which were adequately normally 
distributed) were tested using a paired-samples t-test to explore differences in predicted 
cigarettes per day amongst participants who did not predict being abstinent. 
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3.0  RESULTS 
3.1 SAMPLE BASELINE CHARACTERISTICS 
In total, 71 eligible participants completed the single laboratory session. However, three 
participants were excluded from all analyses. One participant explicitly stated that he saw the 
Quest logo on the study cigarettes and knew that they were identical. The second participant 
misunderstood instructions and smoked both study cigarettes during the first experimental 
smoking session. The third participant marked “very low nicotine cigarette” when asked which 
cigarette he had just smoked during both experimental sessions, so it was unclear whether he 
understood the experimental manipulation. The final sample consisted of 68 individuals (38 
male, 30 female) between the ages of 19-65 years (M=40.37, SD=13.05). The racial composition 
of the sample was 41.2% White, 50% Black, 2.9% Asian, and 4.5% mixed race. The mean 
household income for this sample was $23,546.25 (SD= $15,993.40), and 25% of the sample was 
unemployed at the time of the study. For highest level of education obtained, 4.4% of the sample 
had at least some high school education, 47.1% were high school graduates, 35.3% obtained 
some college education or had a 2-year degree, 11.8% were college graduates with a 4-year 
degree, and 1% had a graduate or professional degree.  
The mean number of cigarettes smoked per day was 16.53 (SD=4.76, range=10-30) and 
the mean number of years that participants had been smoking daily was 21.95 years (SD=12.7, 
 16 
range=1-47). The mean baseline CO reading was 16.32 ppm (SD=7.74, range=3-42). About 66% 
of the sample smoked mentholated cigarettes. The mean total score on the FTND for the sample 
was 5.85 (SD=1.60, range=2-9), while the mean average score on the WISDM was 4.42 
(SD=0.93, range=1.97-6.41). On the Stages of Change Questionnaire, 2.9% of participants were 
planning to quit within 30 days of their participation in the study, and 10.3% were seriously 
considering quitting smoking within 6 months of their participation in the study. The mean score 
on the Contemplation Ladder was 4.35 (SD=2.48, range=0-10). 
3.2 MANIPULATION CHECK 
A paired-samples t-test determined that when participants were asked to rate the nicotine content 
of the study cigarettes, the “very low” nicotine cigarette was rated as having significantly lower 
nicotine content (M=23.56, SD=23.54) than the “average” nicotine cigarette (M=40.19, 
SD=23.91), t(67)=-5.09, p<0.001. However, 12 participants rated the “average” nicotine cigarette 
as having lower nicotine content than the “very low” nicotine cigarette, and nine participants 
rated the study cigarettes equally. Since the nicotine content ratings were made after sampling 
the cigarettes, these participants could have experienced the cigarette in a way that was not 
consistent with the message delivered to them about the nicotine content. For example, these 
participants may have noticed that both cigarettes were very light because of the true very low 
nicotine content. It is unknown, however, what would have driven 12 participants to rate the 
“average” nicotine cigarette as containing lower nicotine than the “very low” nicotine cigarette. 
Nevertheless, since the primary interest for this study was to determine the effects of the very 
low nicotine content expectancy combined with the experience of actually smoking the VLNC 
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cigarette, there was no a priori plan to separate the sample based on this question about 
perceived nicotine content. Thus, the primary outcome data used for final analyses come from 
the total sample. For exploratory purposes, the sample was split between the 47 participants who 
reported nicotine content in the expected direction (“very low” nicotine cigarette less than 
“average” nicotine cigarette) and the 21 participants who reported nicotine content in the 
unexpected direction (“average” nicotine cigarette less than “very low” nicotine cigarette, or 
equal values), and separate analyses were conducted to determine whether effects held for both 
groups. However, it should be noted that splitting the sample in this way could have lead to 
insufficient power issues.  
3.3 HEALTH RISK PERCEPTIONS 
When the data from all 68 participants were analyzed, smokers rated the “very low” nicotine 
cigarette as less risky to their health overall compared to the “average” nicotine cigarette [t(67)=-
3.318, p=0.001]. This effect held true for all individual disease risks assessed including lung 
cancer [t(67)=-4.635, p=<0.001], heart disease [t(67)=-3.953, p<0.001], emphysema [t(67)=-
4.521, p<0.001], stroke [t(67)=-3.738, p<0.001], chronic bronchitis [t(67)=-4.001, p<0.001], and 
other cancers [t(67)=-3.870, p<0.001] (Figure 1). Participants also rated the “very low” nicotine 
cigarette as having a lower addiction risk than the “average” nicotine cigarette [t(67)=-2.647, 
p=0.01].  
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 Figure 1. Ratings for all perceived health risks for usual brand cigarette and both study cigarettes. 
 
Ratings were made on a 1-100 visual analog scale. All p’s<.01 except for addiction risk in which 
p=.01 for “very low nicotine” vs. “average” nicotine comparison. Usual brand cigarette 
responses are displayed for reference but were not included in analyses. 
 
There were no significant interactions between nicotine content expectancy and order of 
study conditions for any of the perceived health risks. There were no significant interactions 
between nicotine content expectancy and gender for any of the perceived health risks, though the 
interaction effect on perceived stroke risk was marginal [F(1,66)=3.014, p=0.09], such that men 
reported a greater difference between study cigarettes. There were no significant interactions 
between nicotine content expectancy and menthol status, though the interaction effect on 
perceived emphysema risk was marginal [F(1,66)=3.322, p=0.07)], such that menthol smokers 
reported a greater difference between study cigarettes. There were no significant interactions 
between nicotine content expectancy and impression management for any perceived health risks.  
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When only the data from the 47 participants who reported lower perceived nicotine 
content for the “very low” nicotine cigarette compared to the “average” nicotine cigarette were 
analyzed, the main effect of nicotine content expectancy on all health risk perceptions reported 
above for the full sample remained statistically significant. When only the data from the other 21 
participants were analyzed, these effects were no longer significant. For these 21 individuals, the 
difference in means (“average” nicotine condition minus “very low” nicotine condition on a 100 
point scale) was 3.63 on average (range 1.05-4.86), compared to 10.78 (range 8.27-14.66) when 
the full sample was analyzed.  
3.4 SUBJECTIVE CIGARETTE EFFECTS 
When the data from all 68 participants were analyzed, smokers rated the “very low” nicotine 
cigarette as having reduced satisfaction [t(67)=-3.481, p=0.001], psychological reward [t(67)=-
2.330, p=0.023], and enjoyment from respiratory sensations [t(67)=-2.913, p=0.005] compared to 
the “average nicotine cigarette” (Figure 2). There was no significant effect of nicotine content 
expectancy on the aversion or craving reduction factors.  
 
 
 
 
 
 
 
 20 
 
Figure 2. Results from the five factors of the Cigarette Evaluation Scale for usual brand cigarette and 
both study cigarettes. 
 
Ratings were made on a 1-7 Likert scale. *p<.05, **p<.01 for “very low nicotine” vs. “average 
nicotine” comparison. The ratings for the usual brand cigarette are displayed for reference but 
were not included in statistical analyses.  
 
There were no significant interactions between nicotine content expectancy and order of 
study conditions for any of the subjective effects factors. There was a significant interaction 
between nicotine content expectancy and gender on enjoyment of respiratory tract sensations 
[F(1,66)=4.361, p=0.041], such that when men were told the study cigarette contained average 
nicotine they reported greater enjoyment of respiratory tract sensations compared to when they 
were told the study cigarette contained very low nicotine and compared to women in both study 
conditions. A similar expectancy by gender interaction effect was marginal for psychological 
reward [F(1,66)=3.234, p=0.08] and craving reduction [F(1,66)=1.492, p=0.07]. There were no 
significant interactions between nicotine content expectancy and menthol status for any of the 
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subjective effects factors. There were no significant interactions between nicotine content 
expectancy and impression management, though the interaction effect was marginal on the 
craving reduction scale [F(1,66)=3.529, p=0.07] in a counterintuitive manner such that 
participants lower on the impression management scale reported a greater difference. 
When only the data from the 47 participants who reported lower perceived nicotine 
content for the “very low” nicotine cigarette compared to the “average” nicotine cigarette were 
analyzed, the main effects of nicotine content expectancy on the five MCES factors reported 
above for the full sample remained the same. When only the data from the other 21 participants 
were analyzed, these effects were no longer significant. For these 21 individuals, the difference 
in means (“average” nicotine condition minus “very low” nicotine condition on a 7 point scale) 
was 0.26 for satisfaction, 0.06 for psychological reward, and 0 for enjoyment of respiratory 
sensations, compared to 0.56 (satisfaction), 0.23 (psychological reward), and 0.47 (enjoyment of 
respiratory sensations) when the full sample was analyzed. 
3.5 PUFF TOPOGRAPHY 
Only 60 participants had useable puff topography data due to eight individuals having used new 
equipment that was not functioning properly. Most participants followed instructions (by 
smoking only four puffs of the usual brand cigarette), but ten participants took five puffs and one 
participant took nine puffs. Paired-samples t-tests revealed no significant differences in any puff 
topography indices across the two study cigarettes (Table 1), though there was a marginal 
difference in total puff volume such that participants inhaled more from the “average” nicotine 
cigarette (p=0.08).  
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Table 1. Results from puff topography for usual brand cigarette and both study cigarettes. 
 
Usual Brand 
Cigarette 
M(SD) 
“Very Low Nicotine” 
Cigarette 
M(SD) 
“Average Nicotine” 
Cigarette 
M(SD) 
t value 
Number of Puffs 4.87 (.93) 7.53 (3.74) 8.05 (3.81) -1.509 
Total Puff Volume 
(mL) 
 
285.44 (97.51) 368.96 (163.5) 397.88 (186.86) 
 
-1.780# 
Average Puff 
Volume (mL) 
 
59.40 (20.15) 50.66 (14.38) 50.48 (15.23) 
 
.151 
Puff Duration 
(ms) 
 
2066.83 (693.96) 1686.92 (527.31) 1717.82 (569.67) 
 
-.620 
Inter-puff Interval 
(ms) 
 
14658.15 (10239.97) 14645.69 (8902.35) 14335.74 (7335.57) 
 
.322 
Average Flow 
(mL/sec) 
29.88 (7.51) 
31.53 (7.52) 31.17 (7.74) 
 
.693 
Peak Flow 
(mL/sec) 
41.81 (11.77) 
43.99 (13.58) 43.44 (12.91) 
 
.626 
Time of Peak Flow 
(ms) 
649.01 (281.13) 
582.94 (252.68) 598.34 (253.46) 
 
-.586 
CO Boost (ppm) 0.5 (1.88) 1.98 (2.32) 1.86 (2.08) .142 
N=60. #p<0.10. Usual brand cigarette values are displayed for reference but were not included 
in analyses. The number of puffs was constrained to 4 puffs for the usual brand cigarette, which 
also affects total puff volume. 
 
The results of the repeated measures ANOVA model that included order of study 
conditions determined that participants inhaled a significantly greater puff volume from the 
“average” nicotine cigarette compared to the “very low” nicotine cigarette [F(1,58)=3.916, 
p=0.053] and inhaled a lower puff volume from the second cigarette compared to the first 
cigarette [F(1,58)=4.80, p=0.03) (Figure 3). There were no other interactions between nicotine 
content expectancy and order of study conditions on any other puff topography indices. There 
were no significant interactions between nicotine content expectancy and gender on any puff 
topography indices, though there was a marginal interaction effect on average puff volume, such 
that the difference between men and women was greater when they were told the study cigarette 
contained average nicotine content [F=(1,58)=2.825, p=0.10]. There were no significant 
interactions between nicotine content expectancy and menthol status on any puff topography 
indices.  
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 Figure 3. Effects of nicotine content expectancy and order of experimental conditions on total puff 
volume. 
 Interaction effect (expectancy X order) was significant with p=0.03. 
 
When only the data from the 40 participants who had useable puff topography data and 
reported a lower perceived nicotine content for the “very low” nicotine cigarette compared to the 
“average” nicotine cigarette were analyzed, the main effect of nicotine content expectancy on 
total puff volume became significant [F(1,38)=5.658, p=0.023], such that smokers inhaled less 
puff volume from the “very low” nicotine cigarette, and the interaction between expectancy and 
order became marginal [F(1,38)=3.233, p=0.08]. When only the data from the other 21 
participants were analyzed, the difference in total puff volume (“average” nicotine condition 
minus “very low” nicotine condition) was -5.69 mL, which was not a significant difference and 
was in the opposite direction compared to when the full sample was analyzed. 
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3.6 PREDICTED FUTURE SMOKING BEHAVIOR 
Responses about predicted quit interest at four future time points were tested using Wilcoxon 
matched pairs tests because the distributions were not normal. When data from all 68 participants 
were analyzed, participants predicted greater interest in quitting smoking when considering 
exclusive availability of the “very low” nicotine cigarette compared to the “average” nicotine 
cigarette in 1 month (Z=-2.496, p=0.013), 6 months (Z=-2.442, p=0.015), and 1 year (Z=-2.636, 
p=0.008) (Table 2). This effect was marginal at 5 years (Z=-1.794, p=0.073). Furthermore, when 
data from all 68 participants were analyzed, McNemar’s tests determined that significantly more 
participants predicted being abstinent in 1 year and 5 years when considering exclusive 
availability of the “very low” nicotine cigarette compared to the “average” nicotine cigarette 
(Table 3). This effect was marginally significant for the 1 month and 6 months time points 
(Table 3). When differences in predicted cigarettes per day (with all 0 responses removed) at the 
four time points were tested with a paired samples t-test, there was no significant effect of 
nicotine content expectancy (Table 2).  
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Table 2. Results from the Future Smoking Survey for usual brand cigarette and both study 
cigarettes. 
On the Future Smoking Survey, participants rated their predicted quit interest on a 1-100 visual 
analog scale. Data was not normally distributed for predicted quit interest, so median and range 
values are presented. Means and standard deviations are presented for predicted cigarettes per 
day. Usual brand cigarette values are displayed for reference but were not included in analyses. 
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Table 3. Percentage of participants that predicted abstinence (smoking zero cigarettes per day) on 
Future Smoking Survey for four time points for usual brand cigarettes and both study cigarettes. 
The corrected chi-square is corrected for continuity with Yates correction, which is often too 
conservative; thus, the uncorrected chi-square statistic from the McNemar’s test was interpreted 
for these analyses. *p<.05, #p<1.0 for “very low nicotine” vs. “average” nicotine comparison. 
Usual brand cigarette responses are displayed for reference but were not included in analyses. 
 
Separate Wilcoxon matched pairs tests were performed to explore whether effects of 
nicotine content expectancy on predicted quit interest differed by gender or menthol status. 
However, it should be noted that these analyses are exploratory and insignificant findings 
(particularly for the smaller of the dichotomous groups) could be a result of insufficient power 
due to dividing the sample. For males (N=38), all results mentioned above for the full sample 
remained the same. However, for females (N=30), none of the effects approached significance 
and the Z scores were significantly lower. For menthol smokers (N=45), effects remained 
significant except at the 5-year time point (Z=-0.65, p=0.52). For non-menthol smokers (N=23), 
the effect at 1 month was marginally significant (p=0.08) and the effect at 5 years was significant 
(p=0.02), while the effects at 6 months and 1 year approached marginal significance.  
In addition, separate McNemar’s tests were conducted to explore whether effects of 
nicotine content expectancy on predicted abstinence differed by gender or menthol status. Again, 
it should be noted that these analyses are exploratory and insignificant findings (particularly for 
the smaller of the dichotomous groups) could be a result of insufficient power due to dividing the 
sample. Significantly more men predicted being abstinent in 1 month (p=0.02) and 5 years 
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(p=0.01) when considering exclusive availability of the “very low” nicotine cigarette, and this 
effect was marginal at 6 months (p=0.01) and 1 year (p=0.06). For women, this effect did not 
approach marginal significance for any of the four time points. Similarly, for non-menthol 
smokers, this effect did not approach marginal significance for any of the four time points. 
However, for menthol smokers, the effect was significant at 5 years (p=0.005), and marginal at 1 
month (p=0.06) and 1 year (p=0.06) 
When only the data from the 47 participants who reported lower perceived nicotine 
content for the “very low” nicotine cigarette compared to the “average” nicotine cigarette were 
analyzed, the significant effects of nicotine content expectancy on predicted quit interest reported 
above for the full sample remained significant, and the effect at the 5 year time point became 
significant (Z=-2.696, p=0.01). When only these data were analyzed for predicted abstinence, 
the effect of nicotine content expectancy became significant for the 1 month time point 
(uncorrected chi-square= 5.444, p=0.02) and remained significant for the 5 year time point, but 
was insignificant for the 6 months and 1 year time points. When only the data from the other 21 
participants were analyzed, there were no significant effects of nicotine content expectancy on 
predicted quit interest for any of the four time points. For these 21 individuals, the results of the 
Wilcoxon matched pairs test were as follows: Z=-0.659, p=0.51 for 1 month, Z=-0.621, p=0.54 
for 6 months, Z=-0.769, p=0.44 for 1 year, and Z=-0.909, p=0.36 for 5 years. When only the data 
from these 21 participants were analyzed for predicted abstinence at the four time points, there 
was a significant effect at the 1 year time point (uncorrected chi-square = 12.8, p=0.00). For 
these 21 individuals, the percentages of participants that predicted abstinence in the “very low” 
nicotine condition were 4.8% in 1 month, 4.8% in 6 months, 9.5% in 1 year, and 19% in 5 years 
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compared to 4.8% in 1 month, 0% in 6 months, 0% in 1 year, and 14.3% in 5 years in the 
“average” nicotine condition. 
3.7 CIGARETTE PURCHASE TASK 
Similar to procedures from Chase, MacKillop, Hogarth (2003), nine individuals that responded 
with zero cigarettes per day when they were hypothetically free or reported they would only 
smoke cigarettes if they were free were excluded from analyses. This occurred six times in the 
“very low” nicotine condition and four times in the “average” nicotine condition. Four 
individuals that responded with the same value across all price increments were excluded 
because this violates the assumption that consumption generally decreases as price increases. 
Seven participants were excluded from analyses because the R2 value (fit of the demand curve 
equation) was unacceptably low (less than 0.4). Thus, data from a total of 48 participants was 
analyzed. The R2, intensity, and Q0 parameters were normally distributed, but elasticity (α), Omax, 
Pmax, and breakpoint were not. Paired-samples t-tests revealed no significant differences between 
the two study conditions for R2, intensity, or Q0 (Table 4). Wilcoxon matched pairs tests revealed 
no significant differences between the two study conditions for elasticity (α), Omax, Pmax, or 
breakpoint (Table 4).  
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Table 4. Results from the Cigarette Purchase Task for usual brand cigarette and both study 
cigarettes. 
T values are presented for variables that were normally distributed and tested using the paired-
samples t-test. Z scores are presented for variables that were not normally distributed and were 
tested using the Wilcoxon matched pairs test. There were no significant findings. Usual brand 
cigarette responses are displayed for reference but were not included in analyses. 
 
Repeated measures ANOVA determined no significant interactions between nicotine 
content expectancy and order of study conditions, gender, or menthol status for Q0 or intensity. 
However, there was a marginal interaction between nicotine content expectancy and gender on 
the intensity parameter [F(1,46)=3.33, p=0.07], such that intensity was higher for men versus 
women in the “very low” nicotine condition. For the elasticity (α), Omax, Pmax, and breakpoint 
parameters, separate Wilcoxon matched pairs tests were conducted to explore differences by 
order of study conditions, gender, and menthol status. These tests revealed similar insignificant 
results across all groups and parameters.  
Results from analyses of the full sample remained insignificant when the 34 participants 
who reported lower perceived nicotine content for the “very low” nicotine cigarette compared to 
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the “average” nicotine cigarette were analyzed separately. There were also no significant 
differences when data from the other 14 participants were analyzed separately. 
3.8 EXPLORATORY ANALYSIS OF RELATIONSHIP BETWEEN DEPENDENT 
MEASURES 
Since the results of puff topography and predicted future smoking behavior generally ran 
opposite to hypotheses, exploratory Pearson’s correlations were conducted to determine how 
these constructs were related to perceived health risks and subjective effects. In both the 
“average” nicotine and “very low” nicotine cigarette conditions, total puff volume was 
significantly positively related to positive subjective effects such as psychological reward, 
satisfaction, and enjoyment of respiratory sensations (Table 5). Similarly predicted future quit 
interest was significantly positively related to these positive subjective effects (Table 5). 
However, health risk perceptions were not significantly related to total puff volume or predicted 
future quit interest (Table 5). 
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Table 5. Exploratory relationships between smoking behavior variables, subjective effects, and 
health risk perceptions for both study cigarettes. 
Values presented are r values from Pearson’s correlations. **p<.01, *p<.05, #p<1.0. 
 
 32 
4.0  DISCUSSION 
The results from the present study were expected in some aspects but somewhat 
surprising in others. The hypotheses that drove this study stemmed primarily from previous 
survey literature highlighting smokers’ misconceptions about the harms of nicotine as well as 
previous literature on “light” cigarettes that demonstrated compensatory smoking and decreased 
interest in quitting when smokers assumed lower harm from these products. Thus, it was 
expected that if risk perceptions of cigarette smoking were reduced due to a very low nicotine 
content expectancy, short-term and predicted long-term future smoking behavior would 
simultaneously increase. The data confirmed that when smokers are given a VLNC cigarette and 
are aware of the very low nicotine content, they believe it is safer than an identical cigarette that 
they are told has average nicotine content. This finding was consistent across a range of disease 
types so it appears to be a general misconception, not just about one particular health problem. 
However, smokers interestingly reported that they would be more interested in quitting smoking 
in the future if only the “very low” nicotine cigarette was available to them, compared to if only 
the “average” nicotine cigarette was available to them, even though they perceived the “very 
low” nicotine cigarette to be less risky to their health. Additionally, there was some evidence that 
smokers inhaled less total puff volume from a VLNC cigarette when they knew it contained very 
low nicotine content. At the same time, when smokers were aware that the study cigarette 
contained very low nicotine they reported significantly fewer desirable subjective effects than 
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when they believed it contained average nicotine. Though this study did not set out to 
specifically explore mechanisms, one possible interpretation of the data is that the more proximal 
positive effects of smoking (i.e. desirable subjective effects) may drive smoking behavior more 
than distal negative health consequences. In fact, an exploratory analysis determined that total 
puff volume was positively correlated with desirable subjective smoking effects, but unrelated to 
health risk perceptions. Similarly, predicted future quit interest was negatively correlated with 
desirable subjective smoking effects, but generally unrelated to health risk perceptions. Future 
studies will be important to clarify the mechanisms underlying smokers’ short-term and 
predicted long-term future smoking behavior. 
The data presented here may be beneficial for policymakers in the event that the FDA 
enacted a low nicotine product standard for cigarettes. The results from this study suggest that 
making smokers aware of the low nicotine content of VLNC cigarettes could possibly have both 
detrimental and positive consequences. Policymakers should certainly consider the reduced risk 
perceptions, and any information about these cigarettes that conveys low nicotine content should 
be accompanied by communication that VLNC cigarettes are not necessarily safer and still lead 
to the same smoking-related diseases. However, it seems that explicit awareness of the low 
nicotine content decreases smokers’ enjoyment of VLNC cigarettes, which may result in at least 
two possible consequences. One possibility is that smokers may desire these cigarettes less, 
which could promote increased quitting. This consequence would clearly be a benefit and its 
potential is generally supported by the data presented here. Conversely, another possibility is that 
smokers may believe that they need to smoke more VLNC cigarettes per day to get the effects 
that they desire, which would increase their harm from smoking. This issue was generally not 
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supported by the data presented here, but it should still be surveyed closely to prevent unintended 
consequences of a low nicotine product standard. 
An interesting finding was that the effects of a very low nicotine content expectancy on 
risk perception, subjective cigarette effects, and smoking behavior were generally nonexistent in 
the minority of participants that rated the nicotine content of the study cigarettes after they tried 
them in a way that was inconsistent with the manipulation (i.e. rated the nicotine content of the 
cigarettes equally or reported that the “average” nicotine cigarette contained less nicotine than 
the “very low” nicotine cigarette). This may suggest that labeling of the nicotine content of 
VLNC cigarettes may not be particularly salient for some smokers who may pay more attention 
to their own subjective smoking experience. This may also suggest that for some smokers, even 
perceived nicotine content may not be particularly important for risk perception, subjective 
smoking experience, or smoking behavior. However, it is possible that these analyses were not 
powered enough to determine significant effects, so future studies with larger sample sizes would 
be important to replicate these findings and explore the mechanisms underlying the differences. 
Furthermore, this study was a brief single-session experiment with several limitations, so 
future studies would be beneficial to further explore the effects of a very low nicotine content 
expectancy on smoker’s perceptions and behaviors. First, this study explored the effects on 
objective smoking behavior in a limited way by only measuring puff topography; a longitudinal 
study exploring cigarettes smoked per day over time would provide a much richer dataset to 
make conclusions from. Moreover, because participants were only able to sample the study 
cigarettes through the puff topography device, this was not a natural smoking experience and 
could have influenced ratings of the cigarettes. Secondly, it is possible that the effects of a very 
low nicotine content expectancy on perceptions are short-lived, so it would be helpful for future 
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studies to measure all dependent variables in this study repeatedly over an extended time period 
as perceptions may change with repeated exposure to the products. Third, participants were 
asked to predict their future behavior over the next five years, and people may not be very 
accurate while doing this. Fourth, the same-day, single session design of the study was not ideal. 
This could have lead to reduced desire to smoke the second study cigarette, especially after 
having already tried the first study cigarette and not liking it as much as the usual brand cigarette. 
Either a within-subjects design with two separate study sessions or a between-subjects design 
with more participants might be a better way to explore these research questions. Lastly, the 
participants in this study were not in a nicotine deprived state, so it would be important for future 
studies to explore the impact of deprivation on the measures described here, as effects of a very 
low nicotine content expectancy may be more pronounced. 
In conclusion, the present study suggests that labeling of the nicotine content of VLNC 
cigarettes could make an impact on some smokers and should be considered carefully. The 
possible consequences appear to be fairly complicated and future studies will be important to 
replicate and extend the present findings. Previous literature suggests that a very low nicotine 
cigarette standard could have a large beneficial public health impact, and it will be important for 
policymakers to determine how to maximize this benefit without causing unintended harm. 
Labeling and marketing of VLNC cigarettes is one aspect that could potentially moderate the 
effects of such a product standard.  
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